Joel A Sincavage

Array ( [id] => 6080429 [patent_doc_number] => 20020081613 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-06-27 [patent_title] => 'Association of SIM2 with cancer' [patent_app_type] => new [patent_app_number] => 09/923684 [patent_app_country] => US [patent_app_date] => 2001-08-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 19146 [patent_no_of_claims] => 58 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 39 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0081/20020081613.pdf [firstpage_image] =>[orig_patent_app_number] => 09923684 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6358835 [patent_doc_number] => 20020058340 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-05-16 [patent_title] => 'Down-regulation of single genes and simultaneous down-regulation of multiple genes by nuclear localization of RNA transcripts' [patent_app_type] => new [patent_app_number] => 09/921068 [patent_app_country] => US [patent_app_date] => 2001-08-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 12565 [patent_no_of_claims] => 40 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 47 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0058/20020058340.pdf [firstpage_image] =>[orig_patent_app_number] => 09921068 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1009544 [patent_doc_number] => 06900306 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2005-05-31 [patent_title] => 'Antisense modulation of CoREST expression' [patent_app_type] => utility [patent_app_number] => 09/920671 [patent_app_country] => US [patent_app_date] => 2001-08-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 25303 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 35 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/900/06900306.pdf [firstpage_image] =>[orig_patent_app_number] => 09920671 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6870794 [patent_doc_number] => 20030083484 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-05-01 [patent_title] => 'Antisense modulation of short heterodimer partner-1 expression' [patent_app_type] => new [patent_app_number] => 09/919197 [patent_app_country] => US [patent_app_date] => 2001-07-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 25846 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 33 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0083/20030083484.pdf [firstpage_image] =>[orig_patent_app_number] => 09919197 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6791568 [patent_doc_number] => 20030086912 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-05-08 [patent_title] => 'Antisense modulation of microsomal triglyceride transfer protein expression' [patent_app_type] => new [patent_app_number] => 09/917963 [patent_app_country] => US [patent_app_date] => 2001-07-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 26560 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 33 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0086/20030086912.pdf [firstpage_image] =>[orig_patent_app_number] => 09917963 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1073618 [patent_doc_number] => 06838283 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2005-01-04 [patent_title] => 'Antisense modulation of survivin expression' [patent_app_type] => utility [patent_app_number] => 09/918186 [patent_app_country] => US [patent_app_date] => 2001-07-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 20272 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 36 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/838/06838283.pdf [firstpage_image] =>[orig_patent_app_number] => 09918186 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 946616 [patent_doc_number] => 06964950 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2005-11-15 [patent_title] => 'Antisense modulation of C-reactive protein expression' [patent_app_type] => utility [patent_app_number] => 09/912724 [patent_app_country] => US [patent_app_date] => 2001-07-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 25471 [patent_no_of_claims] => 37 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 61 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/964/06964950.pdf [firstpage_image] =>[orig_patent_app_number] => 09912724 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6636684 [patent_doc_number] => 20020086843 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-07-04 [patent_title] => 'Physiologically active polypeptide and DNA' [patent_app_type] => new [patent_app_number] => 09/902161 [patent_app_country] => US [patent_app_date] => 2001-07-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 5679 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 9 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0086/20020086843.pdf [firstpage_image] =>[orig_patent_app_number] => 09902161 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1182039 [patent_doc_number] => 06737512 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2004-05-18 [patent_title] => 'Human RNase III and compositions and uses thereof' [patent_app_type] => B2 [patent_app_number] => 09/900425 [patent_app_country] => US [patent_app_date] => 2001-07-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 1 [patent_no_of_words] => 16970 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 25 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/737/06737512.pdf [firstpage_image] =>[orig_patent_app_number] => 09900425 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6697271 [patent_doc_number] => 20030109465 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-06-12 [patent_title] => 'Transforming growth factor beta (TGF- beta) blocking agent-treated stem cell composition and method' [patent_app_type] => new [patent_app_number] => 09/900115 [patent_app_country] => US [patent_app_date] => 2001-07-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 18761 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 64 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0109/20030109465.pdf [firstpage_image] =>[orig_patent_app_number] => 09900115 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6668853 [patent_doc_number] => 20030113837 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-06-19 [patent_title] => 'Tyrosine recombinase for genetic engineering' [patent_app_type] => new [patent_app_number] => 09/895435 [patent_app_country] => US [patent_app_date] => 2001-06-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 13 [patent_no_of_words] => 14649 [patent_no_of_claims] => 52 [patent_no_of_ind_claims] => 12 [patent_words_short_claim] => 18 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0113/20030113837.pdf [firstpage_image] =>[orig_patent_app_number] => 09895435 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6838857 [patent_doc_number] => 20030036197 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-02-20 [patent_title] => 'Recombinant constructs and their use in reducing gene expression' [patent_app_type] => new [patent_app_number] => 09/887194 [patent_app_country] => US [patent_app_date] => 2001-06-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 23478 [patent_no_of_claims] => 45 [patent_no_of_ind_claims] => 35 [patent_words_short_claim] => 27 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0036/20030036197.pdf [firstpage_image] =>[orig_patent_app_number] => 09887194 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1101409 [patent_doc_number] => 06815180 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2004-11-09 [patent_title] => 'Human cervical cancer 1 protooncogene and protein encoded therein' [patent_app_type] => B1 [patent_app_number] => 09/868474 [patent_app_country] => US [patent_app_date] => 2001-06-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 21 [patent_figures_cnt] => 34 [patent_no_of_words] => 10898 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 17 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/815/06815180.pdf [firstpage_image] =>[orig_patent_app_number] => 09868474 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6096672 [patent_doc_number] => 20020052334 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-05-02 [patent_title] => 'Compositions and methods for treating neoplastic disease using inhibitors of laminin5beta3' [patent_app_type] => new [patent_app_number] => 09/876176 [patent_app_country] => US [patent_app_date] => 2001-06-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 12662 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 17 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0052/20020052334.pdf [firstpage_image] =>[orig_patent_app_number] => 09876176 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6177799 [patent_doc_number] => 20020156035 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-10-24 [patent_title] => 'Compositions and methods for treating neoplastic disease using net-4 modulators' [patent_app_type] => new [patent_app_number] => 09/875440 [patent_app_country] => US [patent_app_date] => 2001-06-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 14068 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 18 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0156/20020156035.pdf [firstpage_image] =>[orig_patent_app_number] => 09875440 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5921734 [patent_doc_number] => 20020115140 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-08-22 [patent_title] => 'Rath genes and polypeptides and methods for the treatment and diagnosis of immune disorders' [patent_app_type] => new [patent_app_number] => 09/873438 [patent_app_country] => US [patent_app_date] => 2001-06-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 33153 [patent_no_of_claims] => 57 [patent_no_of_ind_claims] => 15 [patent_words_short_claim] => 12 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0115/20020115140.pdf [firstpage_image] =>[orig_patent_app_number] => 09873438 [rel_patent_id] =>[rel_patent_doc_number] =>)